Novo Nordisk

Page 3 of 8

Novo Nordisk invests $1.2 billion in new Danish factory to expand beyond insulin and weight-loss
Tech

Novo Nordisk invests $1.2 billion in new Danish factory to expand beyond insulin and weight-loss

By
December 16, 2024
Close-up of a patient administering a dose of Zepbound (tirzepatide)
Health

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

By
December 4, 2024
Mads Krogsgaard Thomsen, chief executive officer of Novo Nordisk Foundation, during a panel session on day two of the World Economic Forum (WEF) in Davos, Switzerland, on Tuesday, May 24, 2022.
Health

Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ as ‘fundamentally different’ for Denmark’s economy

By
November 26, 2024
Novo Nordisk launches Wegovy in China with prices well below U.S.
Health

Novo Nordisk launches Wegovy in China with prices well below U.S.

By Amber Tong and Bloomberg
November 18, 2024
Novo Nordisk’s Wegovy sales jump on international rollouts
Retail

Novo Nordisk’s Wegovy sales jump on international rollouts

By Naomi Kresge and Bloomberg
November 6, 2024
Many hundred of spectators watch Queen Margrethe of Denmark while the Royal Guard takes her through the city of Kalundborg in a coach during her visit to the city where she commence a two days visit on June 13, 2017 in Kalundborg, Denmark.
Lifestyle

Danish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness

By
November 4, 2024
A hand is seen holding Ozempic.
Health

Novo’s main Ozempic plant cited for quality lapses by FDA

By Madison Muller and Bloomberg
October 29, 2024
Despite the ubiquitousness of injectable GLP-1 drugs indicated for people with obesity, most Americans wouldn’t take them, according to a September 2024 survey from the Physicians Committee for Responsible Medicine.
Health

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

By
October 10, 2024
Ozempic goes from threat to opportunity for packaged-food makers
Health

Ozempic goes from threat to opportunity for packaged-food makers

By Deena Shanker and Bloomberg
October 2, 2024
A person holds up a box of Ozempic.
Health

Ozempic may help manage opioid addiction: study

By Naomi Kresge and Bloomberg
September 25, 2024
Tesla CEO Elon Musk attends the 10th Annual Breakthrough Prize Ceremony at Academy Museum of Motion Pictures.
Health

Elon Musk and Bernie Sanders say they agree on one thing—cheaper Ozempic

By
September 25, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023.
Health

Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders

By
September 24, 2024
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
Finance

Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’

By Sara Sjolin, Sanne Wass, Oliver Crook and Bloomberg
September 23, 2024
Roche stock is falling after report its Wegovy challenger is causing patients to vomit
Health

Roche stock is falling after report its Wegovy challenger is causing patients to vomit

By Naomi Kresge and Bloomberg
September 12, 2024
Ozempic maker has developed a pill that can cause weight loss of up to 13% in three months
Health

Ozempic maker has developed a pill that can cause weight loss of up to 13% in three months

By
September 11, 2024

Most Popular